rAAV-Mediated Cochlear Gene Therapy: Prospects and Challenges for Clinical Application
Abstract
Over the last decade, pioneering molecular gene therapy for inner-ear disorders have achieved experimental hearing improvements after a single local or systemic injection of adeno-associated, virus-derived vectors (rAAV for recombinant AAV) encoding an extra copy of a normal gene, or ribozymes used to modify a genome. These results hold promise for treating congenital or later-onset hearing loss resulting from monogenic disorders with gene...
Paper Details
Title
rAAV-Mediated Cochlear Gene Therapy: Prospects and Challenges for Clinical Application
Published Date
Feb 21, 2020
Journal
Volume
9
Issue
2
Pages
589 - 589
Citation AnalysisPro
You’ll need to upgrade your plan to Pro
Looking to understand the true influence of a researcher’s work across journals & affiliations?
- Scinapse’s Top 10 Citation Journals & Affiliations graph reveals the quality and authenticity of citations received by a paper.
- Discover whether citations have been inflated due to self-citations, or if citations include institutional bias.
Notes
History